bioAffinity Technologies (BIAF) Change in Receivables (2022 - 2026)
bioAffinity Technologies (BIAF) posted quarterly Change in Receivables of $143274.0 for Q1 2026, up 181.66% year-over-year from $50868.4 in Q1 2025, and up 54.1% quarter-over-quarter from $92972.0 in Q4 2025.
bioAffinity Technologies (BIAF) Change in Receivables (2022 - 2026) Analysis & Trends
bioAffinity Technologies (BIAF) has reported Change in Receivables for 5 consecutive years, with $143274.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Receivables rose 181.66% year-over-year to $143274.0; the TTM figure through Mar 2026 stood at -$278508.0 (down 74.21% YoY), while the FY2025 annual figure was -$597242.0, down 282.35% from the prior year.
- Change in Receivables rose to $143274.0 in Q1 2026 per BIAF's latest filing, from $92972.0 in the prior quarter.
- Across five years, Change in Receivables topped out at $472017.0 in Q2 2024 and bottomed at -$541875.0 in Q2 2025.
- Historically, Change in Receivables has averaged -$25226.2 across 5 years, with a median of $956.0 in 2022.
- Annual changes were most pronounced in 2023 — Change in Receivables slumped 42949.02% — and 2024, when it jumped 57880.48%.
- bioAffinity Technologies' Change in Receivables stood at $559.0 in 2022, then plunged by 42949.02% to -$239526.0 in 2023, then rose by 21.53% to -$187964.0 in 2024, then soared by 149.46% to $92972.0 in 2025, then jumped by 54.1% to $143274.0 in 2026.
- Business Quant data shows BIAF's Change in Receivables at $143274.0 in Q1 2026, $92972.0 in Q4 2025, and $27121.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | - |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | -71.00 Mn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | 4.37 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | -12.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | - |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 26.04 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 26.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 25.09 Mn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 59.20 Mn |
| 10 | bioAffinity Technologies | 1.78 Mn | -649,139.45 | - | 209,587.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 209,587.00 |
| Jun 30, 2026 | 209,587.00 |
| Mar 31, 2026 | 143,274.00 |
| Mar 31, 2026 | 143,274.00 |
| Dec 31, 2025 | 92,972.00 |
| Dec 31, 2025 | 92,972.00 |
| Sep 30, 2025 | 27,121.00 |
| Sep 30, 2025 | 27,121.00 |
| Jun 30, 2025 | -541,875.00 |
| Jun 30, 2025 | -541,875.00 |
| Mar 31, 2025 | -175,460.00 |
| Mar 31, 2025 | -175,460.00 |
| Dec 31, 2024 | -187,964.00 |
| Dec 31, 2024 | -187,964.00 |
| Sep 30, 2024 | -268,458.00 |
| Sep 30, 2024 | -268,458.00 |
| Jun 30, 2024 | 472,017.00 |
| Jun 30, 2024 | 472,017.00 |
| Mar 31, 2024 | 311,935.00 |
| Mar 31, 2024 | 311,935.00 |